WORK Medical director files initial Form 3

WORK Medical Technology Group LTD director Johnson Robert Brian filed an initial Form 3 as a reporting person of the company.

Accepted by SEC EDGAR 06/02/2026 - 12:49 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

WORK Medical Technology Group LTD director Johnson Robert Brian filed an initial Form 3 as a reporting person of the company. This filing establishes his status as a director under insider reporting rules but shows no reportable share holdings or transactions at this time.

Key Terms

Form 3, reporting person, ten percent owner

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

""reportingPersons": [ { "name": "Johnson Robert Brian""

ten percent owner regulatory

""is_ten_percent_owner": 0"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Johnson Robert Brian’s Form 3 for WOK indicate?

The Form 3 shows that Johnson Robert Brian is a director of WORK Medical Technology Group LTD and is now identified as a reporting insider. It does not list any reportable share holdings or transactions in this filing.

Are any WOK share transactions reported in this Form 3 filing?

No share transactions are reported. The transactionSummary shows zero buys, sells, exercises, gifts, tax withholdings, or restructurings. This Form 3 functions purely as an initial insider status filing for the director.

Does the WOK Form 3 show Johnson Robert Brian as a ten percent owner?

No, the Form 3 indicates he is not a ten percent owner. He is identified solely as a director of WORK Medical Technology Group LTD, with no additional ownership category flagged in this filing.

Are there any derivative securities disclosed in WOK’s Form 3?

No derivative securities are disclosed. The derivativeSummary is empty, and derivativeTransactionCount is zero, indicating no reportable options, warrants, or other derivative positions for this reporting person in the filing.

What does the transactionSummary section show for the WOK Form 3?

The transactionSummary lists zero buys, sells, exercises, gifts, and other dispositions, with netBuySellDirection marked as neutral. This confirms there are no reportable trading activities associated with this initial insider filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Johnson Robert Brian

(Last) (First) (Middle)

6904 SW 104TH CT

(Street)

MIAMI FLORIDA 33173-1380

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
WORK Medical Technology Group LTD [ WOK ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Robert Brian Johnson	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)